$COCH is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $COCH, including 1 bill. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
$COCH is currently facing 1 active congressional signal tracked by HillSignal. With 1 bullish, and 0 bearish signal, covering 1 sector. Key sectors affected include Healthcare. Recent major catalysts include Hearing Device Coverage Clarification Act. Below is the complete tracker of government activity affecting $COCH’s market performance.
HR1921 is a narrow, early-stage bill that would reclassify fully implanted active middle ear hearing devices as prosthetics under Medicare, removing the hearing aid coverage exclusion. The bill has no dollar authorization, minimal legislative momentum (3 cosponsors, referred to committee in March 2025), and no market impact observed. The primary structural beneficiaries are pure-play manufacturers of these implantable devices, namely Enova Medical (ENPH) and Cochlear (COCH), but passage probability is low at this stage.